Advertisement
Cancer Types

Leukemia

  • Searching the Blood for Signs of Altered Immunity

    The immune systems of people with blood cancer respond differently to infection with the coronavirus than the immune systems of people without cancer or with solid tumors.

    by Kate Yandell

  • A Drive for Diversity

    African Americans are underrepresented in the Be The Match bone marrow donor registry. Patient advocates are working to change that.

    by Jon Kelvey

  • Forward Look

    Watch Your Mouth

    Dental screening before treatment could stave off dental emergencies.

    by Nancy Averett

  • Q&A

    The Lost Poetry of Patient Stories

    Medical histories capture a vital snapshot of a patient's health status. In his new book, hematologist-oncologist Mikkael A. Sekeres provides a richer narrative.

    by Marci A. Landsmann

  • Keeping CLL in Check

    With recent advances in targeted treatments, people diagnosed with chronic lymphocytic leukemia have more options to manage the disease.

    by Kendall K. Morgan

  • Get Involved

    Filling a Void

    A mother whose son was diagnosed with Burkitt leukemia works to improve access to mental health services for teenagers.

    by Elizabeth Rosto Sitko

  • Despite Generic Imatinib, Cost of Treating CML Remains High

    The arrival of generic versions of the targeted therapy imatinib only modestly reduced the cost of treating chronic myelogenous leukemia patients, a study finds.

    by Anna Azvolinsky

  • When Cancer Becomes an Unwanted Priority

    Amanda Rose Ferraro's leukemia diagnosis forced her to spend time at the hospital away from her 3-year-old-son. She calls focusing on her health and leaving her son “the hardest thing I have ever had to do.”

    by Amanda Rose Ferraro

  • Clinical Trials: An African American Survivor’s Experience

    Melvin Mann benefited from joining a pivotal clinical trial for chronic myelogenous leukemia, but participation came with logistical challenges.

    by Melvin Mann

  • Finding More Targets for CAR-T Cells

    CAR-T cell therapy has successfully treated some patients with leukemia and lymphoma. Researchers are looking to expand the range of cancers that will respond to the therapy.

    by Kendall K. Morgan